We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lawmakers Question FDA’s Grasp of Biosimilars Legislation
Lawmakers Question FDA’s Grasp of Biosimilars Legislation
January 18, 2011
As the FDA continues its internal deliberations over how to regulate biosimilars, the principal authors of the bill that created the approval pathway have written to the agency seeking to clarify what they see as an error in the FDA’s interpretation of the law.